Guangdong Kanghua Healthcare Group Co Ltd

Guangdong Kanghua Healthcare Group Co Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.22, indicating a relatively low reliance on debt financing. The company's liquidity position is moderate, as reflected by a current ratio of 1.35, suggesting it can cover its short-term obligations but with limited buffer. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. Profitability metrics show a return on equity (ROE) of 6.6% and a return on assets (ROA) of 3.72%. These figures are below the industry median for healthcare providers, indicating that the company is generating returns at a slower pace than its peers. The operating margin, calculated as operating income of 158.26 million CNY on revenue of 2.024 billion CNY, is 7.82%, which is in line with the industry's average operating margin of 8.0%. The company's revenue is distributed across four segments: Hospital Services, Rehabilitation and Other Healthcare Services, Haemodialysis Services, and Elderly Healthcare Services. The domestic market accounts for the majority of its operations, with no significant international exposure. The revenue concentration within the domestic market may pose a risk in the event of regulatory or economic shifts in China. Looking ahead, the company is projected to experience a 4.5% year-over-year revenue growth in the current fiscal year, with a further 3.2% growth expected in the following year. This growth trajectory is supported by the expansion of its elderly healthcare services and the increasing demand for haemodialysis services in China. The risk assessment highlights a medium liquidity risk and a low dilution risk. The company has not issued additional shares recently, and there is no indication of imminent dilution pressure. However, the negative net cash position after debt subtraction suggests that the company may need to raise capital in the near term, which could affect its capital structure. Recent filings and transcripts indicate that the company is focusing on expanding its elderly healthcare services and improving the efficiency of its hospital operations. There are no major regulatory or legal issues reported in the latest filings, and the company continues to operate within the domestic market without significant international exposure.